FilingReader Intelligence
Nordhealth boosts AI investment, cuts profit target
August 13, 2025 at 07:09 PM UTC•By FilingReader AI
Nordhealth is increasing 2025 product development expenditure by €3.1m, focusing on AI feature development across its Veterinary and Therapy business units and accelerating Provet Cloud localisation for DACH markets.
The company revised its 2025 'Adj. EBITDA - CAPEX' target from between -€2.0m and +€2.0m to between -€4.0m and -€2.0m.
Growth guidance for 'Vet + Therapy recurring revenue' remains unchanged at 12% to 17% compared to 2024.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
OSL:NORDH•Oslo Stock Exchange
News Alerts
Get instant email alerts when Nordhealth AS publishes news
Free account required • Unsubscribe anytime